Loading...
Loading...
Toggle sidebar
Search Ctrl + K
Filing information
TAKEDA PHARMACEUTICAL CO LTD
Filing: 20-F
Filed On: 2021-06-29
Email Link to Filing
Print Filing
Download PDF
Download all tables
Your filing highlights
Compare documents
EDGAR Index Page
Documents
20-F
20-F
EX-1.2
exhibit12_062921.htm
EX-2.2
exhibit22_062921.htm
EX-4.1
Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
EX-12.1
Statements re computation of ratios
EX-12.2
exhibit122_062921.htm
EX-13.1
Annual report to security holders, Form 10-Q and 10-QSB, or quarterly report to security holders
EX-13.2
exhibit132_062921.htm
EX-15.1
Letter re unaudited interim financial information
EX-15.2
exhibit152_062921.htm
GRAPHIC
logo.jpg
GRAPHIC
tak-20210331_g1.jpg
0001395064-21-000140.txt
Data files
EX-101.SCH
tak-20210331.xsd
EX-101.CAL
tak-20210331_cal.xml
EX-101.DEF
tak-20210331_def.xml
EX-101.LAB
tak-20210331_lab.xml
EX-101.PRE
tak-20210331_pre.xml
XML
tak-20210331_htm.xml
Free Trial
Save highlight
Link to highlight
Your browser does not support iframes.